by Timmerman Report
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Language
🇺🇲
Publishing Since
9/13/2017
Email Addresses
1 available
Phone Numbers
0 available
April 14, 2025
Kevin Parker, CEO of Cartography Biosciences, on finding new cancer drug targets.
March 31, 2025
David Roblin, CEO of London-based Relation Therapeutics, on building a techbio discovery company.
March 16, 2025
Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.
STAT
Matt Pillar
Andreessen Horowitz, a16z Bio + Health
BioCentury
Biotech 2050
Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more
Eric Topol
Andreessen Horowitz
All-In Podcast, LLC
Levine Media Group
Colossus | Investing & Business Podcasts
Ben Gilbert and David Rosenthal
Vinay Prasad, MD MPH
Bloomberg
Alex Kantrowitz
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.